Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis.
第一作者:
N H,Bjarnason
第一单位:
Center for Clinical & Basic Research, Ballerup, Denmark. nina.bjarnason@post.tele.dk
作者:
医学主题词
碱性磷酸酶(Alkaline Phosphatase);骨重建(Bone Remodeling);卡方分布(Chi-Square Distribution);胶原(Collagen);酶联免疫吸附测定(Enzyme-Linked Immunosorbent Assay);雌激素拮抗剂(Estrogen Antagonists);女(雌)性(Female);人类(Humans);Logistic模型(Logistic Models);多元分析(Multivariate Analysis);骨钙素(Osteocalcin);骨质疏松, 绝经后(Osteoporosis, Postmenopausal);危险因素(Risk Factors);脊柱骨折(Spinal Fractures)
DOI
10.1007/s001980170020
PMID
11808544
发布时间
2022-04-10
- 浏览9
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



